Can-DESyNe will operate distinctly from Genome Canada by administration through a newly created SynBio Centre of Innovation and Entrepreneurship (CIE). The CIE, National Synthetic Biology Steering Committee, Genome Canada Enterprise and key Partners will define the governance necessary for transparent and fair decision-making for project selection and IP ownership.
National Synthetic Biology Steering Committee
Dr. Bettina Hamelin, President and CEO, Ontario Genomics (Chair) - BIO
Dr. Vincent Martin, Director, Centre for Applied Synthetic Biology, Concordia University - BIO
Dr. Peter Zandstra, Director, Michael Smith Laboratories, University of British Columbia - BIO
Dr. Keith Pardee, Canada Research Chair in Synthetic Biology and Human Health, University of Toronto - BIO
Dr. Roman Szumski, VP Life Sciences, National Research Council - BIO
Dr. Doane Chilcoat, Leader, Applied Science and Technology at Coretva Agriscience - BIO
Andrew Casey, President and CEO, BIOTECanada - BIO
Dr. Krishna Mahadevan, Professor, University of Toronto - BIO
PARTNER WITH US
Benefits include leading or participating in
projects, accessing customers, technology partners &
academic experts, and leveraging your investment dollars.